FindTrial
Sign In

Postoperative liver decompensation and other complications in hepatocellular carcinoma patients with clinically significant portal hypertension treated by microwave ablation and laparoscopic hepatectomy

Postoperative liver decompensation and other complications in hepatocellular carcinoma patients with clinically significant portal hypertension treated by microwave ablation and laparoscopic hepatectomy

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300068396
Enrollment
Unknown
Registered
2023-02-17
Start date
2023-02-13
Completion date
Unknown
Last updated
2023-05-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hepatocellular Carcinoma

Interventions

Microwave ablation:N/A
Laparoscopic resection:N/A

Sponsors

Shandong Provincial Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 90 Years

Inclusion criteria

Inclusion criteria: HCC patients with CSPH were included in this study. Inclusion criteria: (a) age > 18 years; (b) Child-Pugh class A or B; and (c) no vascular invasion or distant metastasis.

Exclusion criteria

Exclusion criteria: Patients were excluded based on the exclusion criteria as follows: (a) patients did not achieve complete ablation after MWA or did not achieve R0 resection for LR; and (b) other significant comorbidities such as COPD, heart failure or renal failure or a history of other malignancies.

Design outcomes

Primary

MeasureTime frame
Postoperative liver decompensation;—

Secondary

MeasureTime frame
Complications;Overall survival;Local tumor progression ;—

Countries

China

Contacts

Public ContactZhao Xinya

Shandong Provincial Hospital

961132410@qq.com0531 68776200

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026